Anti-perlecan antibodies and acute humoral rejection in hypersensitized patients without forbidden HLA specificities after kidney transplantation

Tait, 2010, Solid phase HLA antibody detection technology—challenges in interpretation, Tissue Antigens, 76, 87 Sanfilippo, 1982, Comparative effects of pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results, Transplantation, 34, 360, 10.1097/00007890-198212000-00010 Dilioglou, 2001, High panel reactive antibody against cross-reactive group antigens as a contraindication to renal allotransplantation, Exp. Mol. Pathol., 71, 73, 10.1006/exmp.2001.2356 Claas, 1989, Transplantation in hyperimmunized patients, Adv. Nephrol. Necker Hosp., 18, 317 Cecka, 2010, Calculated PRA (CPRA): the new measure of sensitization for transplant candidates, Am. J. Transplant., 10, 26, 10.1111/j.1600-6143.2009.02927.x Morris, 2010, Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation, Hum. Immunol., 71, 268, 10.1016/j.humimm.2010.01.003 Johnson, 2016, Renal transplantation with final allocation based on the virtual crossmatch, Am. J. Transplant., 16, 1503, 10.1111/ajt.13606 Reinsmoen, 2014, Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome, Transplantation, 97, 595, 10.1097/01.TP.0000436927.08026.a8 Reinsmoen, 2017, Immunological risk stratification by assessing both the HLA and non-HLA-specific antibodies: time to include testing for Non-HLA antibodies in the routine clinical antibody analysis profile?, Transplantation, 101, 23, 10.1097/TP.0000000000001495 Philogene, 2018, Pre-transplant screening for non-HLA antibodies: who should be tested?, Hum. Immunol., 79, 195, 10.1016/j.humimm.2018.02.001 Valentin, 2016, Implementation of a national priority allocation system for hypersensitized patients in Spain, based on virtual crossmatch: initial results, Transplant. Proc., 48, 2871, 10.1016/j.transproceed.2016.09.024 Irure, 2017, Improvement in the definition of anti-HLA antibody profile in highly sensitized patients, PLoS One, 12, 10.1371/journal.pone.0171463 Haas, 2014, An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts, Curr. Opin. Organ Transplant., 19, 315, 10.1097/MOT.0000000000000072 Haas, 2018, The Banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials, Am. J. Transplant., 18, 293, 10.1111/ajt.14625 Gareau, 2018, Pre-transplant AT1R antibodies correlate with early allograft rejection, Transpl. Immunol., 46, 29, 10.1016/j.trim.2017.12.001 Banasik, 2014, The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes, Transplant Int., 27, 1029, 10.1111/tri.12371 Banasik, 2014, The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes, Transpl. Immunol., 30, 24, 10.1016/j.trim.2013.10.007 Giral, 2013, Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss, Am. J. Transplant., 13, 2567, 10.1111/ajt.12397 Sanchez-Zapardiel, 2013, Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period, Transplantation, 96, 70, 10.1097/TP.0b013e3182943506 Cardinal, 2013, Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury, Am. J. Transplant., 13, 861, 10.1111/ajt.12168 Yang, 2016, Anti-LG3 antibodies aggravate renal ischemia-reperfusion Injury and long-term renal allograft dysfunction, Am. J. Transplant., 16, 3416, 10.1111/ajt.13866 Ismail, 2008, Does pre-transplant in vitro detection of anti-endothelial cell antibodies predict renal allograft outcome?, Egyptian J. Immunol., 15, 115 Sanchez-Zapardiel, 2016, Isolated de novo antiendothelial cell antibodies and kidney transplant rejection, Am. J. Kidney Dis., 68, 933, 10.1053/j.ajkd.2016.07.019 Hachem, 2012, Antibodies to K-alpha 1 tubulin and collagen V are associated with chronic rejection after lung transplantation, Am. J. Transplant., 12, 2164, 10.1111/j.1600-6143.2012.04079.x O'Leary, 2017, Non-HLA antibodies impact on C4d staining, stellate cell activation and fibrosis in liver allografts, Transplantation, 101, 2399, 10.1097/TP.0000000000001853